ArticleBMC cancer2019

Cetuximab, irinotecan and fluorouracile in fiRst-line treatment of immunologically-selected advanced colorectal cancer patients: the CIFRA study protocol.

Alessandro Ottaiano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.